Clinical Research Division, Fred Hutch
Dr. Diane Tseng studies the immune response to lung cancer with the goal of developing new lung cancer immunotherapies. She studies how immune cells called T cells recognize tumor cells in the lungs. Her research has found that T cells within tumors that recognize viruses, such as the Epstein-Barr virus that causes mononucleosis, can also react to tumor cells. Now she is learning how important these cross-reactive immune cells might be in tumor biology and to the outcomes of people with lung tumors. In addition to her laboratory research, Dr. Tseng treats patients with lung cancer and other solid tumors.
University of Washington School of Medicine, Department of Medicine, Division of Medical Oncology
Seattle Cancer Care Alliance
Stanford University, Cancer Cell Therapy Center
2013: M.D. Ph.D., Stanford University School of Medicine
2006: BS, Biological Sciences, Stanford University
Advancing immunotherapies for the treatment of lung cancer patients
Understanding T cell cross-reactivity to viral and tumor antigens in lung cancer
Discovering novel T cell specificities in lung cancer
Head and neck cancers
— Dr. Diane Tseng
The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.
Email email@example.com or call 206.667.2210.